THE USE OF NICOTINAMIDE TEST DOSE IN THE ASSESSMENT OF PSYCHOTROPIC DRUGS IN SCHIZOPHRENIC PATIENTS.
D035843:Biomedical Research; D002707:Chlordiazepoxide; D002746:Chlorpromazine; D006801:Humans; D007099:Imipramine; D007785:Lactose; D009525:Niacin; D009536:Niacinamide; D011600:Psychopharmacology; D011619:Psychotropic Drugs; D012559:Schizophrenia; D014268:Trifluoperazine; D014556:Urine
D011619:Psychotropic Drugs; D014268:Trifluoperazine; D009536:Niacinamide; D009525:Niacin; D002707:Chlordiazepoxide; D007785:Lactose; D007099:Imipramine; D002746:Chlorpromazine
CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLINICAL RESEARCH; IMIPRAMINE; LACTOSE; NICOTINAMIDE; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; TRIFLUOPERAZINE; URINE